Fennec Pharmaceuticals Inc (FENC)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.38B
EV to revenue ratio (TTM)
5.01
EV to ebitda
20.27
Financial Performance
Revenue (TTM)
$0.06B
Gross profit (TTM)
$0.06B
EBITDA
-$0.00B
Profitability
Operating margin (TTM)
9.72%
Profit margin
-5.49%
Return on assets (TTM)
-1.17%
Return on equity (TTM)
-18.60%
Per Share Metrics
Revenue per share (TTM)
$1.85
EPS
-$0.12
Diluted EPS (TTM)
-$0.12
Book value
$1.21
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
11.17
PEG ratio
1.47
Price to sales ratio (TTM)
6.41
Price to book ratio (TTM)
8.11
Growth
Quarterly earnings growth (YoY)
85.20%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
2
Buy
4
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.21